Cargando…

Discovery of SARS-CoV-2-E channel inhibitors as antiviral candidates

Lack of efficiency has been a major problem shared by all currently developed anti-SARS-CoV-2 therapies. Our previous study shows that SARS-CoV-2 structural envelope (2-E) protein forms a type of cation channel, and heterogeneously expression of 2-E channels causes host cell death. In this study we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yi, Fang, Sui, Wu, Yan, Cheng, Xi, Zhang, Lei-ke, Shen, Xu-rui, Li, Shuang-qu, Xu, Jian-rong, Shang, Wei-juan, Gao, Zhao-bing, Xia, Bing-qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295639/ https://www.ncbi.nlm.nih.gov/pubmed/34294887 http://dx.doi.org/10.1038/s41401-021-00732-2

Ejemplares similares

Inhibitory Effects of Antiviral Drug Candidates on Canine Parvovirus in F81 cells
por: Zhou, Hongzhuan, et al.
Publicado: (2019)

Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
por: Dai, Wenhao, et al.
Publicado: (2020)

Antiviral Drug Discovery: Norovirus Proteases and Development of Inhibitors
por: Chang, Kyeong-Ok, et al.
Publicado: (2019)

SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries
por: Elshabrawy, Hatem A.
Publicado: (2020)

Discovery of inhibitors against SARS-CoV-2 main protease using fragment-based drug design
por: Shao, Hai Ping, et al.
Publicado: (2023)

Inhibitors of Nucleotide Biosynthesis as Candidates for a Wide Spectrum of Antiviral Chemotherapy
por: Sepúlveda, Claudia Soledad, et al.
Publicado: (2022)

Identification of Potent and Safe Antiviral Therapeutic Candidates Against SARS-CoV-2
por: Xiao, Xia, et al.
Publicado: (2020)

Facilitating Antiviral Drug Discovery Using Genetic and Evolutionary Knowledge
por: Xu, Xuan, et al.
Publicado: (2021)

Discovery of M Protease Inhibitors Encoded by SARS-CoV-2
por: Hung, Hui-Chen, et al.
Publicado: (2020)

Discovery of Potential M2 Channel Inhibitors Based on the Amantadine Scaffold via Virtual Screening and Pharmacophore Modeling
por: Tran, Linh, et al.
Publicado: (2011)

Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2
por: Xiong, Rui, et al.
Publicado: (2020)

Current Strategies of Antiviral Drug Discovery for COVID-19
por: Mei, Miao, et al.
Publicado: (2021)

Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?
por: Santos, Igor de Andrade, et al.
Publicado: (2020)

SARS-CoV-2 M(pro) inhibitors with antiviral activity in a transgenic mouse model
por: Qiao, Jingxin, et al.
Publicado: (2021)

Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2
por: Xiong, Rui, et al.
Publicado: (2020)

Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2
por: Xiong, Rui, et al.
Publicado: (2020)

Discovery of MAO-B Inhibitor with Machine Learning, Topomer CoMFA, Molecular Docking and Multi-Spectroscopy Approaches
por: Zheng, Linfeng, et al.
Publicado: (2022)

A comprehensive procedure for antiviral inhibitor discovery using EV71 as an example
por: Cao, Lin, et al.
Publicado: (2015)

Structure-based discovery of two antiviral inhibitors targeting the NS3 helicase of Japanese encephalitis virus
por: Fang, Jin’e, et al.
Publicado: (2016)

Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer’s Disease
por: Son, Minky, et al.
Publicado: (2019)

SARS‐CoV‐2–host proteome interactions for antiviral drug discovery
por: Liu, Xiaonan, et al.
Publicado: (2021)

Antiviral Agents: Discovery to Resistance
por: Adamson, Catherine S.
Publicado: (2020)

Comparative Antiviral Efficacy of Viral Protease Inhibitors against the Novel SARS-CoV-2 In Vitro
por: Zhang, Leike, et al.
Publicado: (2020)

Hydroxamate and thiosemicarbazone: Two highly promising scaffolds for the development of SARS-CoV-2 antivirals
por: Xu, Yin-Sui, et al.
Publicado: (2022)

Erratum to: A comprehensive procedure for antiviral inhibitor discovery using EV71 as an example
por: Cao, Lin, et al.
Publicado: (2016)

Discovery of Novel Andrographolide Derivatives as Antiviral Inhibitors against Human Enterovirus A71
por: Tan, Jie Kai, et al.
Publicado: (2022)

Discovery of SARS-CoV-2 Antivirals through Large-scale Drug Repositioning
por: Riva, Laura, et al.
Publicado: (2020)

The discovery of antivirals and novel targets for SARS-CoV-2 and EV-A71
por: Haddad, Christina, et al.
Publicado: (2022)

The nucleocapsid protein of zoonotic betacoronaviruses is an attractive target for antiviral drug discovery
por: Lang, Yuekun, et al.
Publicado: (2021)

Current Landscape of Antiviral Drug Discovery
por: Blair, Wade, et al.
Publicado: (2016)

Recommender Systems in Antiviral Drug Discovery
por: Sosnina, Ekaterina A., et al.
Publicado: (2020)

Structural biology in antiviral drug discovery
por: Bassetto, Marcella, et al.
Publicado: (2016)

Discovery of Antivirals Using Phage Display
por: Sokullu, Esen, et al.
Publicado: (2021)

The Discovery of Naringenin as Endolysosomal Two-Pore Channel Inhibitor and Its Emerging Role in SARS-CoV-2 Infection
por: D’Amore, Antonella, et al.
Publicado: (2021)

Discovery of novel immunotherapeutic drug candidates for sciatic nerve injury using bioinformatic analysis and experimental verification
por: Li, Shengyou, et al.
Publicado: (2022)

Identification of Site-Specific Stroke Biomarker Candidates by Laser Capture Microdissection and Labeled Reference Peptide
por: Lian, Tingting, et al.
Publicado: (2015)

Discovery of Novel Conotoxin Candidates Using Machine Learning
por: Li, Qing, et al.
Publicado: (2018)

Discovery of a new inhibitor targeting PD-L1 for cancer immunotherapy
por: Wang, Fengling, et al.
Publicado: (2021)

Antiviral therapy of HCV in the cirrhotic and transplant candidate
por: Herrine, Steven K., et al.
Publicado: (2006)

Engineering a Reliable and Convenient SARS-CoV-2 Replicon System for Analysis of Viral RNA Synthesis and Screening of Antiviral Inhibitors
por: Luo, Yuewen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gu2e7aj3h3fijr0om7vjj808ek